SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TheraTech (THRT)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert Stewart who wrote (28)12/30/1996 1:22:00 AM
From: Ying Wang   of 125
 
Marlin,

I got my info from the annual report. GLP-1 is in phase I trial.
Because of the big potential, any positive news should pop the stock
price. There is only one phase III trial on Testosterone 5 mg
system, similar to the already approved 2.5mg system. Two more
phase II trials, one on Oral Controlled Release the other on Estradiol/
progestin patch. The company has very rich pipeline (at lease a dozen
to ~20 leads).

Ying
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News